FDA Considers OTC Fat Blocker

January 23, 2006

The Food and Drug Administration is deciding if it should accept GlaxoSmithKline Consumer Healthcare’s proposal to market its Alli (pronounced “ally”) fat blocker medication for sale over-the-counter.

Recent News